Determination of anticoagulant activity of heparin
Dalmora, S.L.; Assaf, G.S.; Dalmora, M.E.; Vaucher, L.C.; Vaccari, S.F.
Revista do Hospital das Clinicas 46(2): 59-62
1991
ISSN/ISBN: 0041-8781 PMID: 1843369 Document Number: 387234
Heparin samples from four manufacturers and the First Argentinian Standard Heparin obtained from porcine mucosa were assayed by the Reinert and Winterstein method, modified as suggested by USP and Brazilian Pharmacopeias. Other methods described in the literature and their importance for the evaluation of anticoagulant activity of unfractionated heparins with low molecular weight are discussed.
Document emailed within 1 workday
Related Documents
Sampol, J.; Rossi, J.M.; Lejay, G. 1984: Automatization of heparin determination using chronometric evaluation of anti-Xa activity of the AT III-heparin complex Annales de Biologie Clinique 42(1): 21-23Krupiński, K.; Bielawiec, M.; Breddin, H.K. 1994: Antithrombotic properties of heparin independent of its anticoagulant activity Acta Haematologica Polonica 25(3): 243-251
Ushkalova, E.A.; Kremneva, V.F.; Ovchinnikova, L.K.; Shcheglova, N.V. 1989: Comparative evaluation of the anticoagulant activity of the sodium and calcium salts of heparin, isolated from swine intestinal mucosa Farmakologiia i Toksikologiia 52(3): 51-55
Byshevskiĭ, A.S.; Sokolovskiĭ, S.R. 1982: Potentiation of the anticoagulant effects of a phosphatidylserine-containing anticoagulant and heparin Voprosy Meditsinskoi Khimii 28(2): 30-34
Wilhelmsson, S.; Lins, L.E. 1976: Whole-blood thrombin time: a bedside method for determination of heparin activity Clinical Nephrology 6(6): 523-525
Bychko, S.M.; Kharlamova, V.N. 1975: The anticoagulant properties of different heparin fractions Biulleten' Eksperimental'noi Biologii i Meditsiny 79(2): 61-63
Bremmelgaard, A. 1986: Heparin and monitoring of peroral anticoagulant therapy Ugeskrift for Laeger 148(21): 1275-1276
Ofosu, F.A. 1988: Mechanisms for the anticoagulant effect of heparin and related polysaccharides Nouvelle Revue Francaise d'Hematologie 30(3): 155-160
Millot, F.; Bara, L.; Etienne, J.; Samama, M.; Laruelle, P. 1987: Lipolytic and anticoagulant activities of heparin and one of its low molecular weight derivatives Nouvelle Revue Francaise d'Hematologie 29(6): 397-400
Matsuoka, T.; Inoue, K.; Mizuno, K.; Kita, Y.; Nakanishi, S.; Asai, S.; Taoka, R.; Soda, T.; Terai, A. 2012: Heparin as bridging anticoagulant and antiplatelet therapy during the perioperative period Hinyokika Kiyo. Acta Urologica Japonica 58(5): 223-226
Kudriashov, B.A.; Liapina, L.A.; Azieva, L.D. 1990: The content of a heparin-like anticoagulant in the flowers of the meadowsweet (Filipendula ulmaria) Farmakologiia i Toksikologiia 53(4): 39-41
Jacobs, C.; Grebe, S.; Kietzmann, M.; Mischke, R. 1999: Pharmacokinetics of an unfractionated heparin (Liquemin) in the dog after intravenous and subcutaneous application based on heparin activity Deutsche Tierärztliche Wochenschrift 106(11): 478-481
Strukova, S.M.; Khlebnikova, T.G.; Umarova, B.A.; Kulibali, M. 1984: Heparin secretion by mast cells as an index of the status of the anticoagulant system Biulleten' Eksperimental'noi Biologii i Meditsiny 97(2): 131-134
Völker, W.; Böhm, A.; Schmidt, A.; Svahn, C.M.; Gellerbring, A.K.; Mattsson, C.; Ekvärn, S.; Robenek, H.; Buddecke, E. 1995: Inhibition of smooth muscle cell proliferation and neointimal growth by low-anticoagulant heparin Arzneimittel-Forschung 45(5): 546-550
Shammas, N.W.; Lemke, J.H.; Dippel, E.J.; McKinney, D.E.; Takes, V.S.; Youngblut, M.; Harris, M.; Harb, C.; Kapalis, M.J.; Holden, J. 2003: In-hospital complications of peripheral vascular interventions using unfractionated heparin as the primary anticoagulant Journal of Invasive Cardiology 15(5): 242-246
Burg, M.; Ostendorf, T.; Mooney, A.; Koch, K.M.; Floege, J. 1997: Treatment of experimental mesangioproliferative glomerulonephritis with non-anticoagulant heparin: therapeutic efficacy and safety Laboratory Investigation; A Journal of Technical Methods and Pathology 76(4): 505-516
Schneider, T.; Heuer, B.; Deller, A.; Boesken, W.H. 2000: Continuous haemofiltration with r-hirudin (lepirudin) as anticoagulant in a patient with heparin induced thrombocytopenia (HIT II) Wiener Klinische Wochenschrift 112(12): 552-555
Pomortseva, I.V.; Ovchinnikova, L.K.; Shcheglova, N.V. 1990: The influence of the Soviet antimalarial preparation dabequin on the hemostatic system and on the anticoagulant effect of heparin Farmakologiia i Toksikologiia 53(1): 59-62
Harenberg, J.; Stehle, G.; Dempfle, C.E.; von Hodenberg, E.; Heene, D.L. 1989: The pharmacological profile of the low molecular weight heparin 21-23 in man: anticoagulant, lipolytic and protamine reversible effects Folia Haematologica 116(6): 967-980
Shah, A.C.; Genoni, M.; Niederhäuser, U.; Maloigne, M.; Turina, M. 2000: R-hirudin (lepirudin, refludan) as an alternative anticoagulant in heparin-induced thrombocytopenia during cardiopulmonary bypass connection Schweizerische Medizinische Wochenschrift 130(23): 896-899